3H-spiperone binding capacity in mononuclear cells: a family study

Area of Science:

• Psychiatry and Neuroscience
• Molecular Biology
• Genetics

Background:

• Schizophrenia and schizoaffective disorders are complex psychiatric conditions with suspected genetic components.
• Identifying reliable biological markers is crucial for understanding disease mechanisms and genetic transmission.
• Dopamine system dysregulation is a prominent hypothesis in the pathophysiology of schizophrenia.

Purpose of the Study:

• To investigate the cosegregation of a clinical phenotype of schizophrenia/schizoaffective disorder with a biological marker.
• To examine the binding capacity of the dopamine antagonist spiperone to mononuclear cells as a potential biological marker.
• To determine if this marker is present in families with a history of psychiatric disorders.

Main Methods:

• A family study design was employed.
• The binding capacity of spiperone to mononuclear cells was measured in 21 index probands and 147 relatives (first and second degree).
• Data analysis focused on the co-occurrence of increased spiperone binding with psychiatric diagnoses within families.

Main Results:

• Increased spiperone binding was observed in 17 index probands and their affected relatives, irrespective of clinical diagnosis.
• This increased binding was also found in 22% of unaffected relatives from these families.
• Four index probands and their relatives did not show increased binding, nor did any unaffected relatives in that group.

Conclusions:

• Increased spiperone binding capacity may cosegregate with the genetic risk for functional psychoses.
• This biological marker could potentially differentiate families with a high burden of psychiatric disorders.
• Findings support the utility of biological markers in understanding the genetic basis of severe mental illness.